Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
APOBEC3B is a member of the cytidine deaminase gene family. Additionally we are shipping APOBEC3B Antibodies (51) and APOBEC3B Proteins (4) and many more products for this protein.
SNPs in APOBEC3 alter expression of APOBEC3A/APOBEC3B to affect somatic APOBEC-signature mutations.
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation have been reported.
A lysine-free derivative of human APOBEC3B was constructed and shown to be indistinguishable from the wild-type enzyme in DNA cytosine deamination, HIV-1 restriction, and nuclear localization activities.
exposures to relevant environmental factors might induce APOBEC3A or APOBEC3B expression above genotoxic levels and initiate tumorigenesis in a tissue-specific manner in the right cellular environment where ssDNA is available
APOBEC3B expression increased the incorporation of genomic uracil, invoked DNA damage response (DDR (show DDR1 ELISA Kits)) biomarkers and caused cell cycle arrest.
The findings demonstrate that covalently-closed circular DNA levels are significantly lower in hepatocellular carcinoma tissues, and that the lower levels are likely to stem in part from up-regulation of APOBEC3B.
Data suggest that heat shock proteins, in particular Hsp90, stimulate APOBEC3-mediated DNA deamination activity toward hepatitis B viral DNA, suggesting a potential physiological role in mutagenesis/carcinogenesis and viral innate immunity; Hsp90 stimulates deamination activity of APOBEC3G, APOBEC3B, and APOBEC3C during co-expression in human liver HepG2 cells.
APOBEC3B mRNA levels are significantly higher in breast cancer metastases as compared to the corresponding estrogen receptor (show ESR1 ELISA Kits)-positive primary tumors.
tumour-infiltrating immune cells may be an important feature of breast cancers arising in women with APOBEC3B germline deletion, and that this may be of particular interest in Asian women where the germline deletion is more common.
the APOBEC3B deletion polymorphism has neither a prognostic nor a predictive value for breast cancer patients.
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. A hybrid gene results from the deletion of approximately 29.5 kb of sequence between this gene, APOBEC3B, and the adjacent gene APOBEC3A. The breakpoints of the deletion are within the two genes, so the deletion allele is predicted to have the promoter and coding region of APOBEC3A, but the 3' UTR of APOBEC3B. Two transcript variants encoding different isoforms have been found for this gene.
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
, probable DNA dC->dU-editing enzyme APOBEC-3B
, apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3B
, DNA dC->dU-editing enzyme APOBEC-3B
, cytidine deaminase
, phorbolin 2
, phorbolin 3
, phorbolin-1-related protein
, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
, DNA dC->dU-editing enzyme APOBEC3
, apolipoprotein B editing complex 3
, probable DNA dC->dU-editing enzyme APOBEC3